(1 - 29 from 36
)
Scientists may have achieved first 'in body' gene editing therapy
nypost.com
Feb 7, — “This is a first step,” said Dr. Joseph Muenzer of the University of North Carolina at Chapel Hill, who helped test the treatment. › › scientists-may-have-...
Sangamo stock drops 13% premarket on results of phase
www.marketwatch.com
Sep 5, — Joseph Muenzer, a professor of pediatrics and genetics at the University of North Carolina School of Medicine in Chapel Hill and principal ... › Industries › Biotechnology
Early Results of First In Vivo Gene-Editing Trial Encouraging
www.the-scientist.com
Sep 5, — “I cannot absolutely say it's a treatment effect,” study leader Joseph Muenzer of the University of North Carolina, Chapel Hill, ... › news-opinion › early-re...
History of Changes for Study: NCT Clinical Trials
clinicaltrials.gov
Study Officials: Joseph Muenzer, MD, PhD. Principal Investigator University of North Carolina, Chapel Hill. Locations: United States, North Carolina. › history › NCT
sorted by relevance / date